glp-1 sleep apnea trial Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Syndrome Management: A Narrative Review Will GLP-1 Drugs Disrupt the

the magnitude of HbA1c change in this non-diabetic population was modest, as would be expected Fasting insulin levels decreased, indicating improved insulin sensitivity Triglyceride and lipid profiles showed favourable changes, which may reduce cardiometabolic risk Waist circumference was substantially reduced, reflecting a decrease in visceral (abdominal) adiposity These findings are particularly relevant given that excess visceral fat is strongly associated with type 2 diabetes, cardiovascular disease, and metabolic syndrome

But for serious weight loss support, there are likely more effective supplements out there

Diarrhea or vomiting can cause dehydration

l-Carnitine Supplementation in Recovery after Exercise